This document discusses Takayasu arteritis, a rare inflammatory disease of large arteries. It begins by defining the disease and describing the anatomy of the aorta and its branches that are commonly affected. It then discusses the classification of the disease based on angiography and lists the criteria used for diagnosis. The document concludes by describing the typical symptoms, physical exam findings, and stages of the disease.
Diagnosis, management, workup in a case of Takayasu's arteritis. Definition, synonyms, history, epidimiology, pathophysiology, etiology of Takayasu's arteritis.
Diagnosis, management, workup in a case of Takayasu's arteritis. Definition, synonyms, history, epidimiology, pathophysiology, etiology of Takayasu's arteritis.
I. Introduction
A. Brief explanation of World Hypertension Day
B. Importance of addressing hypertension as a global health issue
C. Overview of the objectives of the presentation
II. Understanding Hypertension
A. Definition and classification of hypertension
B. Prevalence and global burden of hypertension
C. Risk factors and causes of hypertension
D. Health implications and complications associated with hypertension
III. World Hypertension Day 2023
A. Background and significance of World Hypertension Day
B. Theme and key messages for World Hypertension Day 2023
C. Activities and events organized worldwide to raise awareness
IV. Goals and Objectives
A. Key goals set for World Hypertension Day 2023
B. Promoting prevention and early detection of hypertension
C. Encouraging healthy lifestyle modifications
D. Enhancing public knowledge about hypertension management
V. Initiatives and Campaigns
A. Overview of global initiatives and campaigns
B. Collaborations with international organizations, NGOs, and healthcare professionals
C. Campaign materials and resources available for public use
VI. Strategies for Hypertension Prevention and Control
A. Implementing population-level interventions
B. Screening and diagnosis strategies
C. Lifestyle modifications (diet, physical activity, stress management)
D. Pharmacological management and treatment guidelines
VII. Public Awareness and Education
A. Importance of raising public awareness about hypertension
B. Educational campaigns and resources for the general public
C. Role of healthcare professionals in educating patients
VIII. Impact and Achievements
A. Highlighting the impact of previous World Hypertension Day campaigns
B. Success stories and achievements in hypertension prevention and control
C. Lessons learned and areas for improvement
IX. Conclusion
A. Recap of the key points discussed
B. Call to action for individuals, communities, and policymakers
C. Encouragement to spread awareness and take steps towards hypertension prevention
I. Introduction
A. Brief explanation of World Hypertension Day
B. Importance of addressing hypertension as a global health issue
C. Overview of the objectives of the presentation
II. Understanding Hypertension
A. Definition and classification of hypertension
B. Prevalence and global burden of hypertension
C. Risk factors and causes of hypertension
D. Health implications and complications associated with hypertension
III. World Hypertension Day 2023
A. Background and significance of World Hypertension Day
B. Theme and key messages for World Hypertension Day 2023
C. Activities and events organized worldwide to raise awareness
IV. Goals and Objectives
A. Key goals set for World Hypertension Day 2023
B. Promoting prevention and early detection of hypertension
C. Encouraging healthy lifestyle modifications
D. Enhancing public knowledge about hypertension management
V. Initiatives and Campaigns
A. Overview of global initiatives and campaigns
B. Collaborations with international organizations, NGOs, and healthcare professionals
C. Campaign materials and resources available for public use
VI. Strategies for Hypertension Prevention and Control
A. Implementing population-level interventions
B. Screening and diagnosis strategies
C. Lifestyle modifications (diet, physical activity, stress management)
D. Pharmacological management and treatment guidelines
VII. Public Awareness and Education
A. Importance of raising public awareness about hypertension
B. Educational campaigns and resources for the general public
C. Role of healthcare professionals in educating patients
VIII. Impact and Achievements
A. Highlighting the impact of previous World Hypertension Day campaigns
B. Success stories and achievements in hypertension prevention and control
C. Lessons learned and areas for improvement
IX. Conclusion
A. Recap of the key points discussed
B. Call to action for individuals, communities, and policymakers
C. Encouragement to spread awareness and take steps towards hypertension prevention
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
1. Takayasu Arteritis –Anatomy, Classification
Physical examination
Student: Guilherme Lima Paschoalini
Group 29, 5th year
KURSK - 2017
Dr
STATE BUDGETARY EDUCATIONAL ESTABLISHMENT
OF HIGHER PROFESSIONAL EDUCATIONAL
MINISTRY OF PUBLIC HEALTH OF RUSSIAN FEDERATION
KURSK STATE MEDICAL UNIVERSITY
DEPARTMENT OF SURGERY
Head of Department: MD Phd Prof Ivanov. S. V
Teacher: MD Dr Tsukanov. A. V
2. Definition
Takayasu arteritis is a rare, systemic,
inflammatory large-vessel vasculitis of
unknown etiology that most commonly affects
women of childbearing age. It is defined as
"granulomatous inflammation of the aorta and
its major branches"
3. ANATOMY
The aorta can be divided into four
sections: the ascending aorta,
the aortic arch, the thoracic
(descending) aorta and
the abdominal aorta.
4. BRANCHES
Ascending Aorta: left and right coronary arteries
Thoracic Aorta: Bronchial arteries; Mediastinal arteries; Oesophageal arteries;
Pericardial arteries; Superior phrenic arteries; Intercostal and subcostal arteries
Abdominal Aorta: Inferior phrenic arteries; Coeliac artery; Superior mesenteric
artery; Middle suprarenal arteries; Renal arteries; Gonadal arteries; Inferior
mesenteric artery; Median sacral artery; Lumbar arteries.
5.
6. Aortic Arch:
Brachiocephalic trunk: The first and largest branch that ascends laterally
to split into the right common carotid and right subclavian arteries. These
arteries supply the right side of the head and neck, and the right upper
limb.
Left common carotid artery: Supplies the left side of the head and neck.
Left subclavian artery: Supplies the left upper limb.
7.
8. CLASSIFICATION
Angiography-based categories:
Type I - Branches of the aortic arch
Type IIa - Ascending aorta, aortic arch, and its branches
Type IIb - Type IIa region plus thoracic descending aorta
Type III - Thoracic descending aorta, abdominal aorta, renal arteries, or a
combination
Type IV - Abdominal aorta, renal arteries, or both
Type V - Entire aorta and its branches
9.
10. HISTORY
Constitutional symptoms include the following: Headache (50-70%);
Malaise (35-65%); Arthralgias (28-75%); Fever (9-35%); Weight loss (10-
18%)
Cardiac and vascular features include the following: Bruit, with the most
common location being the carotid artery (80%); Blood pressure difference
of extremities (45%-69%); Claudication (38-81%); Carotodynia or vessel
tenderness (13-32%); Hypertension (28-53%; 58% with renal artery
stenosis in one series); Aortic regurgitation (20-24%)
Neurologic features include the following: Headache (50-70%); Visual
disturbance (16-35%) - Strong association with common carotid and
vertebral artery disease; Stroke (5-9%)
11. Classification criteria
The American College of Rheumatology has established classification
criteria for Takayasu arteritis (3 of 6 criteria are necessary).
Age of 40 years or younger at disease onset
Claudication of the extremities
Decreased pulsation of one or both brachial arteries
Difference of at least 10 mm Hg in systolic blood pressure between arms
Bruit over one or both subclavian arteries or the abdominal aorta
Arteriographic narrowing or occlusion of the entire aorta, its primary branches, or
large arteries in the upper or lower extremities that is not due to arteriosclerosis,
fibromuscular dysplasia, or other causes
12. STAGES
The first stage is an early systemic stage during which the patient may complain of
constitutional symptoms (eg, fatigue, malaise, giddiness, fever). This stage is
considered to be prevasculitic.
The second stage is the vascular inflammatory stage when stenosis, aneurysms, and
vascular pain (carotidynia) tend to occur.
The third stage is the burned-out stage, when fibrosis sets in, and generally is
associated with remission.
13.
14. PHYSICAL EXAMINATION
A thorough physical examination is essential, with particular attention paid to peripheral
pulses, blood pressure in all 4 extremities, and ophthalmologic examination. The most
discriminatory finding is a systolic blood pressure difference (>10 mm Hg) between
arms.
Hypertension due to renal artery involvement (and sometimes leading to hypertensive
encephalopathy) is found in approximately 50% of patients. Carotidynia may be present.
Aortic regurgitation is a common finding.
Absent or diminished pulses are the clinical hallmark of Takayasu arteritis, but pulses are
normal in many patients and upper limbs are affected more often than lower limbs.
Ophthalmologic examination may show retinal ischemia, retinal hemorrhages, cotton-
wool exudates, venous dilatation and beading.
15. Complete occlusion of the left common carotid artery in a 48-
year-old woman with Takayasu disease.
17. Narrowing of the proximal descending aorta and right
brachiocephalic artery.
18. REFERENCES
Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL. Nomenclature of systemic vasculitides. Proposal of an international
consensus conference. Arthritis Rheum. 1994 Feb. 37(2):187-92. [Medline].
Hata A, Noda M, Moriwaki R, Numano F. Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol. 1996 Aug. 54
Suppl:S155-63. [Medline].
Numano F, Kobayashi Y. Takayasu arteritis--beyond pulselessness. Intern Med. 1999 Mar. 38(3):226-32. [Medline]. [Full Text].
Arnaud L, Haroche J, Mathian A, Gorochov G, Amoura Z. Pathogenesis of Takayasu's arteritis: a 2011 update. Autoimmun Rev. 2011 Nov.
11(1):61-7. [Medline].
Aggarwal A, Chag M, Sinha N, Naik S. Takayasu's arteritis: role of Mycobacterium tuberculosis and its 65 kDa heat shock protein. Int J
Cardiol. 1996 Jul 5. 55(1):49-55. [Medline].
Kumar Chauhan S, Kumar Tripathy N, Sinha N, Singh M, Nityanand S. Cellular and humoral immune responses to mycobacterial heat
shock protein-65 and its human homologue in Takayasu's arteritis. Clin Exp Immunol. 2004 Dec. 138(3):547-53. [Medline]. [Full Text].
Soto ME, Vargas-Alarcón G, Cicero-Sabido R, Ramírez E, Alvarez-León E, Reyes PA. Comparison distribution of HLA-B alleles in mexican
patients with takayasu arteritis and tuberculosis. Hum Immunol. 2007 May. 68(5):449-53. [Medline].
Yagi K, Kobayashi J, Yasue S, Yamaguchi M, Shiobara S, Mabuchi H. Four unrelated cases with Takayasu arteritis and CD36 deficiency:
possible link between these disorders. J Intern Med. 2004 Jun. 255(6):688-9. [Medline].
Hall S, Barr W, Lie JT, Stanson AW, Kazmier FJ, Hunder GG. Takayasu arteritis. A study of 32 North American patients. Medicine
(Baltimore). 1985 Mar. 64(2):89-99. [Medline].